Search Results - "Benito Boíllos, Alberto"

Use of Machine-Learning Algorithms in Intensified Preoperative Therapy of Pancreatic Cancer to Predict Individual Risk of Relapse by Sala Elarre, Pablo, Oyaga-Iriarte, Esther, Yu, Kenneth H, Baudin, Vicky, Arbea Moreno, Leire, Carranza, Omar, Chopitea Ortega, Ana, Ponz-Sarvise, Mariano, Mejías Sosa, Luis D, Rotellar Sastre, Fernando, Larrea Leoz, Blanca, Iragorri Barberena, Yohana, Subtil Iñigo, Jose C, Benito Boíllos, Alberto, Pardo, Fernando, Rodríguez Rodríguez, Javier

“…Although surgical resection is the only potentially curative treatment for pancreatic cancer (PC), long-term outcomes of this treatment remain poor. The aim of…”
Get full text

Focal Therapy of Prostate Cancer Index Lesion With Irreversible Electroporation. A Prospective Study With a Median Follow-up of 3 Years by Miñana López, Bernardino, Andrés Boville, Guillermo, Barbas Bernardos, Guillermo, Ancizu Marckert, Xabier, Torres Roca, Marcos, Labairu Huerta, Luis, Villacampa Aubá, Felipe, Ramón de Fata Chillón, Fernando, Sanz Ortega, Julian, Abengózar Muela, Marta, Gallardo Madueño, Guillermo, Benito Boíllos, Alberto, Alcázar Peral, Andrés, Díez-Caballero Alonso, Fernando

“…Our aim was to assess oncologic, safety, and quality of life-related outcomes of focal therapy with irreversible electroporation in men with localized prostate…”
Get full text

Effects of two personalized dietary strategies during a 2‐year intervention in subjects with nonalcoholic fatty liver disease: A randomized trial by Marin‐Alejandre, Bertha A., Cantero, Irene, Perez‐Diaz‐del‐Campo, Nuria, Monreal, Jose I., Elorz, Mariana, Herrero, Jose I., Benito‐Boillos, Alberto, Quiroga, Jorge, Martinez‐Echeverria, Ana, Uriz‐Otano, Juan I., Huarte‐Muniesa, Maria P., Tur, Josep A., Martinez, Jose A., Abete, Itziar, Zulet, Maria A.

“…Background and objectives Nonalcoholic fatty liver disease (NAFLD) management is focused on lifestyle modifications, but long‐term maintenance is a challenge…”
Get full text

The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial by Marin-Alejandre, Bertha Araceli, Abete, Itziar, Cantero, Irene, Monreal, J Ignacio, Elorz, Mariana, Herrero, José Ignacio, Benito-Boillos, Alberto, Quiroga, Jorge, Martinez-Echeverria, Ana, Uriz-Otano, Juan Isidro, Huarte-Muniesa, María Pilar, Tur, Josep A, Martinez, J Alfredo, Zulet, M Angeles

“…The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing worldwide. NAFLD management is mainly focused on weight loss, but the optimal…”
Get full text

Interplay of Glycemic Index, Glycemic Load, and Dietary Antioxidant Capacity with Insulin Resistance in Subjects with a Cardiometabolic Risk Profile by Galarregui, Cristina, Zulet, María Ángeles, Cantero, Irene, Marín-Alejandre, Bertha Araceli, Monreal, José Ignacio, Elorz, Mariana, Benito-Boillos, Alberto, Herrero, José Ignacio, Tur, Josep Antoni, Abete, Itziar, Martínez, José Alfredo

“…Dietary total antioxidant capacity (TAC), glycemic index (GI), and glycemic load (GL) are accepted indicators of diet quality, which have an effect on…”
Get full text

Multipanel Approach including miRNAs, Inflammatory Markers, and Depressive Symptoms for Metabolic Dysfunction-Associated Steatotic Liver Disease Diagnosis during 2-Year Nutritional Intervention by Tobaruela-Resola, Ana Luz, Riezu-Boj, José I, Milagro, Fermin I, Mogna-Pelaez, Paola, Herrero, José I, Elorz, Mariana, Benito-Boillos, Alberto, Tur, Josep A, Martínez, J Alfredo, Abete, Itziar, Zulet, M Angeles

“…Metabolic dysfunction-associated steatotic liver disease (MASLD), with a prevalence of 30% of adults globally, is considered a multifactorial disease. There is…”
Get full text

Association between Sleep Disturbances and Liver Status in Obese Subjects with Nonalcoholic Fatty Liver Disease: A Comparison with Healthy Controls by Marin-Alejandre, Bertha Araceli, Abete, Itziar, Cantero, Irene, Riezu-Boj, Jose I, Milagro, Fermín I, Monreal, J Ignacio, Elorz, Mariana, Herrero, José Ignacio, Benito-Boillos, Alberto, Quiroga, Jorge, Martinez-Echeverria, Ana, Uriz-Otano, Juan Isidro, Huarte-Muniesa, María Pilar, Tur, Josep A, Martínez, J Alfredo, Zulet, M Angeles

“…The relevance of sleep patterns in the onset or evolution of nonalcoholic fatty liver disease (NAFLD) is still poorly understood. Our aim was to investigate…”
Get full text

Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) Study by Recaredo, Gregorio, Marin-Alejandre, Bertha Araceli, Cantero, Irene, Monreal, J Ignacio, Herrero, José Ignacio, Benito-Boillos, Alberto, Elorz, Mariana, Tur, Josep A, Martínez, J Alfredo, Zulet, M Angeles, Abete, Itziar

“…Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome. Obesity and unhealthy dietary habits are described as…”
Get full text

Association of the SH2B1 rs7359397 Gene Polymorphism with Steatosis Severity in Subjects with Obesity and Non-Alcoholic Fatty Liver Disease by Perez-Diaz-Del-Campo, Nuria, Abete, Itziar, Cantero, Irene, Marin-Alejandre, Bertha Araceli, Monreal, J Ignacio, Elorz, Mariana, Herrero, José Ignacio, Benito-Boillos, Alberto, Riezu-Boj, Jose I, Milagro, Fermín I, Tur, Josep A, Martinez, J Alfredo, Zulet, M Angeles

“…Non-alcoholic fatty liver disease (NAFLD) is a major cause of liver disease worldwide. Some genetic variants might be involved in the progression of this…”
Get full text

Three Different Genetic Risk Scores Based on Fatty Liver Index, Magnetic Resonance Imaging and Lipidomic for a Nutrigenetic Personalized Management of NAFLD: The Fatty Liver in Obesity Study by Perez-Diaz-Del-Campo, Nuria, Riezu-Boj, Jose I, Marin-Alejandre, Bertha Araceli, Monreal, J Ignacio, Elorz, Mariana, Herrero, José Ignacio, Benito-Boillos, Alberto, Milagro, Fermín I, Tur, Josep A, Abete, Itziar, Zulet, M Angeles, Martinez, J Alfredo

“…Non-alcoholic fatty liver disease (NAFLD) affects 25% of the global population. The pathogenesis of NAFLD is complex; available data reveal that genetics and…”
Get full text

Predictive Value of Serum Ferritin in Combination with Alanine Aminotransferase and Glucose Levels for Noninvasive Assessment of NAFLD: Fatty Liver in Obesity (FLiO) Study by Galarregui, Cristina, Marin-Alejandre, Bertha Araceli, Perez-Diaz-Del-Campo, Nuria, Cantero, Irene, Monreal, J. Ignacio, Elorz, Mariana, Benito-Boillos, Alberto, Herrero, José Ignacio, Tur, Josep A., Martínez, J. Alfredo, Zulet, M. Angeles, Abete, Itziar

“…The identification of affordable noninvasive biomarkers for the diagnosis and characterization of nonalcoholic fatty liver disease (NAFLD) is a major challenge…”
Get full text

Reply by Authors by Miñana López, Bernardino, Andrés Boville, Guillermo, Barbas Bernardos, Guillermo, Ancizu Marckert, Xabier, Torres Roca, Marcos, Labairu Huerta, Luis, Villacampa Aubá, Felipe, Ramón de Fata Chillón, Fernando, Sanz Ortega, Julian, Abengózar Muela, Marta, Gallardo Madueño, Guillermo, Benito Boíllos, Alberto, Alcázar Peral, Andrés, Díez-Caballero Alonso, Fernando

Get full text

Reply by Authors by Miñana López, Bernardino, Andrés Boville, Guillermo, Barbas Bernardos, Guillermo, Ancizu Marckert, Xabier, Torres Roca, Marcos, Labairu Huerta, Luis, Villacampa Aubá, Felipe, Ramón de Fata Chillón, Fernando, Sanz Ortega, Julian, Abengózar Muela, Marta, Gallardo Madueño, Guillermo, Benito Boíllos, Alberto, Alcázar Peral, Andrés, Díez-Caballero Alonso, Fernando

Get full text

Reply by Authors by Miñana López, Bernardino, Andrés Boville, Guillermo, Barbas Bernardos, Guillermo, Ancizu Marckert, Xabier, Torres Roca, Marcos, Labairu Huerta, Luis, Villacampa Aubá, Felipe, Ramón de Fata Chillón, Fernando, Sanz Ortega, Julian, Abengózar Muela, Marta, Gallardo Madueño, Guillermo, Benito Boíllos, Alberto, Alcázar Peral, Andrés, Díez-Caballero Alonso, Fernando

Get full text

Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial by Mogna-Peláez, Paola, Riezu-Boj, José I., Milagro, Fermin I., Herrero, José I., Elorz, Mariana, Benito-Boillos, Alberto, Tobaruela-Resola, Ana Luz, Tur, Josep A., Martínez, J Alfredo, Abete, Itziar, Zulet, M. Angeles

“…Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing public health concern. The disease is silent, and its diagnosis is often delayed…”
Get full text

Circulating microRNA panels in subjects with metabolic dysfunction-associated steatotic liver disease after following a 2-year dietary intervention by Tobaruela-Resola, Ana Luz, Riezu-Boj, José Ignacio, Milagro, Fermín I., Mogna-Pelaez, Paola, Herrero, José I., Elorz, Mariana, Benito-Boillos, Alberto, Tur, Josep A., Martínez, J. Alfredo, Abete, Itziar, Zulet, María Ángeles

“…Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) affects one-third of the global population. Despite its high prevalence, there is a lack of…”
Get full text

Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) study by Galarregui, Cristina, Cantero, Irene, Marin-Alejandre, Bertha Araceli, Monreal, J. Ignacio, Elorz, Mariana, Benito-Boillos, Alberto, Herrero, José Ignacio, de la O, Víctor, Ruiz-Canela, Miguel, Hermsdorff, Helen Hermana M., Bressan, Josefina, Tur, Josep A., Martínez, J. Alfredo, Zulet, M. Angeles, Abete, Itziar

“…Purpose Identification of dietary factors involved in the development and progression of nonalcoholic fatty liver disease (NAFLD) is relevant to the current…”
Get full text

Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessment by Tobaruela-Resola, Ana Luz, Milagro, Fermín I, Elorz, Mariana, Benito-Boillos, Alberto, Herrero, José I, Mogna-Peláez, Paola, Tur, Josep A, Martínez, J Alfredo, Abete, Itziar, Zulet, M Ángeles

“…Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a worldwide leading cause of liver-related associated morbidities and mortality. Currently,…”
Get full text

Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience by Aliseda, Daniel, Martí-Cruchaga, Pablo, Zozaya, Gabriel, Rodríguez-Fraile, Macarena, Bilbao, José I, Benito-Boillos, Alberto, Martínez De La Cuesta, Antonio, Lopez-Olaondo, Luis, Hidalgo, Francisco, Ponz-Sarvisé, Mariano, Chopitea, Ana, Rodríguez, Javier, Iñarrairaegui, Mercedes, Herrero, José Ignacio, Pardo, Fernando, Sangro, Bruno, Rotellar, Fernando

“…Radioembolization (RE) may help local control and achieve tumor reduction while hypertrophies healthy liver and provides a test of time. For liver transplant…”
Get full text

Association between diet quality indicators and nonalcoholic fatty liver disease: The FLiO study by Galarregui, Cristina, Angeles Zulet, M., Marin-Alejandre, Bertha Araceli, Cantero, Irene, Goodwin, Nora, Ignacio Monreal, J., Elorz, Mariana, Benito-Boillos, Alberto, Tur, Josep A., Alfredo Martínez, J., Abete, Itziar

“…IntroductionDietary components are contributing factors in the development of Nonalcoholic fatty liver disease (NAFLD). The glycaemic index (GI), glycaemic…”
Get full text